Antiglycative activity of sulforaphane: a new avenue to counteract neurodegeneration
Related Faculty: Mansoor Amiji Related Departments:Chemical Engineering
GLP-1 use during early pregnancy may not increase risk of major adverse outcomes Taking GLP-1s during the first trimester of pregnancy does not appear to substantially increase the risk of adverse outcomes, according to a new study led by Harvard T.H
Lonza Group AG
Across the studies, sterile water, distilled water, blank solvent water, or normal saline were used as control interventions
Moreover, IHC analysis of filaggrin and loricrin, key proteins involved in epidermal barrier function, revealed that glutathione amino acid precursors treatment enhanced their levels in UVB-exposed skin, supporting the protective effects of glutathione amino acid precursors on barrier function